Page last updated: 2024-08-25

rosiglitazone and Pancreatitis, Chronic

rosiglitazone has been researched along with Pancreatitis, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
You, S; Zhou, X	1

Other Studies

1 other study(ies) available for rosiglitazone and Pancreatitis, Chronic

Article	Year
Rosiglitazone inhibits hepatic insulin resistance induced by chronic pancreatitis and IKK-β/NF-κB expression in liver. Pancreas, 2014, Volume: 43, Issue:8 Topics: Anilides; Animals; Drug Evaluation, Preclinical; Gene Expression Regulation; Glucose; Glucose Tolerance Test; Hepatocytes; I-kappa B Kinase; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Male; Pancreatitis, Chronic; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Transcription Factor RelA	2014

Article

Year

Rosiglitazone inhibits hepatic insulin resistance induced by chronic pancreatitis and IKK-β/NF-κB expression in liver.

Pancreas, 2014, Volume: 43, Issue:8

Topics: Anilides; Animals; Drug Evaluation, Preclinical; Gene Expression Regulation; Glucose; Glucose Tolerance Test; Hepatocytes; I-kappa B Kinase; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Male; Pancreatitis, Chronic; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Transcription Factor RelA

2014